ACHC Acadia Healthcare Company, Inc.

$28.38 +2.33%

Updated 16 d ago

Healthcare · Services-Specialty Outpatient Facilities, Nec

Acadia Healthcare Company, Inc. (ACHC) is a healthcare company in the Services-Specialty Outpatient Facilities, Nec industry, with a market capitalization of $2.6 billion. Shares last traded at $28.38, 20.7% below their 52-week high. Over the past year the stock is up 21.7%. Net profit margin is -32.8%, below the peer median of -1.5%. Revenue grew 5.0% year over year.

Market Cap

$2.6B

Shares Out

90.8M

EPS (TTM)

$1.38

P/E Ratio

20.56

P/S Ratio

0.76

P/B Ratio

1.32

Dividend / Share

—

Dividend Yield

—

52-Week High

$35.80

52-Week Low

$11.43

Volume

39,063

Avg Vol (3m)

140,515.222

Performance

-6.04%

-12.10%

+12.62%

+15.06%

YTD

+98.70%

+21.68%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.76

SMA (50)

$30.52

SMA (200)

$22.85

Price vs SMA50

-7.04%

Price vs SMA200

+24.16%

ATR (14)

$1.57

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$3.4B

Net Income

$-1107M

Gross Margin

—

Operating Margin

17.4%

Net Margin

-32.8%

Return on Equity

-56.5%

Return on Assets

-20.0%

Current Ratio

1.71

Debt / Equity

1.29

Revenue Growth (YoY)

+5.0%

Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.05	2026-04-30
FY 2025	$-12.16	2026-02-27
Q3 2025	$0.82	2025-11-05
Q2 2025	$0.42	2025-08-05
Q1 2026	$0.09	2026-04-30
FY 2025	$2.78	2026-02-27

Full earnings history →

Healthcare peers

ACHC vs 14 sector peers (Healthcare), by market cap. Updated 16 d ago

P/S vs peers

0.76 / 4.47 med

-83% discount

Net margin vs peers

-32.8% / -1.5% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
AMGN	Amgen	$240.1B	27.47	6.30	23.0%	+0.31%
TMO	Thermo Fisher Scientific	$228.7B	32.82	4.94	15.0%	+1.66%
KLAC	KLA Corporation	$225.9B	46.76	16.64	35.6%	+0.37%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
GILD	Gilead Sciences	$187.5B	-57.87	6.16	-10.6%	+1.09%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
DHR	Danaher Corporation	$148.3B	37.05	5.91	15.9%	+0.49%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.